Showing 2 posts of 2 posts found.
US drugs giant Pfizer is to pay more than $784 million to settle claims that it overcharged health insurer Medicaid …
Pfizer and Takeda are to split $2.15 billion in damages from two generics manufacturers as a settlement for lost sales, …
Qureight paper argues for fibrosis extent as imaging biomarker in lung disease trials
START and Rome cancer institute partner to expand early-phase trial access in Italy
AbbVie expands Oxford R&D facility with new £120m UK research commitment
MedPharm appoints Jason Mieding as chief operating officer
UKRI backs five hubs developing AI tools for earlier disease detection